TIGD6
gene geneOn this page
Also known as DKFZp761E2110
Summary
TIGD6 (tigger transposable element derived 6, HGNC:18332) is a protein-coding gene on chromosome 5q32, encoding Tigger transposable element-derived protein 6 (Q17RP2).
The protein encoded by this gene belongs to the tigger subfamily of the pogo superfamily of DNA-mediated transposons in humans. These proteins are related to DNA transposons found in fungi and nematodes, and more distantly to the Tc1 and mariner transposases. They are also very similar to the major mammalian centromere protein B.
Source: NCBI Gene 81789 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 96 total
- Dosage sensitivity (ClinGen): haploinsufficiency dosage sensitivity unlikely, triplosensitivity no evidence
- MANE Select transcript:
NM_030953
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18332 |
| Approved symbol | TIGD6 |
| Name | tigger transposable element derived 6 |
| Location | 5q32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp761E2110 |
| Ensembl gene | ENSG00000164296 |
| Ensembl biotype | protein_coding |
| Entrez | 81789 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000296736, ENST00000515406, ENST00000532987, ENST00000893998, ENST00000915769
RefSeq mRNA: 4 — MANE Select: NM_030953
NM_001243253, NM_001412170, NM_001412172, NM_030953
CCDS: CCDS4301
Canonical transcript exons
ENST00000296736 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001083170 | 149993118 | 149996429 |
| ENSE00001211682 | 150000474 | 150000654 |
Expression profiles
Bgee: expression breadth ubiquitous, 179 present calls, max score 79.31.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.3731 / max 108.5483, expressed in 1727 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 64146 | 1.8454 | 1218 |
| 64147 | 1.6736 | 1140 |
| 64148 | 0.8541 | 590 |
Top tissues by expression
273 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.31 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.13 | gold quality |
| islet of Langerhans | UBERON:0000006 | 78.09 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.88 | gold quality |
| buccal mucosa cell | CL:0002336 | 77.64 | silver quality |
| right adrenal gland cortex | UBERON:0035827 | 75.94 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 75.92 | gold quality |
| left adrenal gland | UBERON:0001234 | 75.91 | gold quality |
| right adrenal gland | UBERON:0001233 | 75.89 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 75.70 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 75.63 | gold quality |
| rectum | UBERON:0001052 | 74.91 | gold quality |
| adenohypophysis | UBERON:0002196 | 74.55 | gold quality |
| calcaneal tendon | UBERON:0003701 | 74.30 | gold quality |
| tibial nerve | UBERON:0001323 | 74.25 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.74 | gold quality |
| adrenal gland | UBERON:0002369 | 73.39 | gold quality |
| adrenal cortex | UBERON:0001235 | 73.29 | gold quality |
| transverse colon | UBERON:0001157 | 73.09 | gold quality |
| ventricular zone | UBERON:0003053 | 72.73 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 72.54 | gold quality |
| spinal cord | UBERON:0002240 | 72.05 | gold quality |
| popliteal artery | UBERON:0002250 | 72.04 | gold quality |
| tibial artery | UBERON:0007610 | 72.03 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 72.02 | gold quality |
| lower esophagus | UBERON:0013473 | 72.01 | gold quality |
| left coronary artery | UBERON:0001626 | 71.88 | gold quality |
| pancreas | UBERON:0001264 | 71.80 | gold quality |
| left ovary | UBERON:0002119 | 71.79 | gold quality |
| aorta | UBERON:0000947 | 71.69 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.64 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
79 targeting TIGD6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-5680 | 99.91 | 69.83 | 3421 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-8062 | 99.88 | 68.43 | 995 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-1299 | 99.77 | 71.24 | 2389 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
| HSA-MIR-3689A-3P | 99.70 | 65.73 | 2306 |
| HSA-MIR-3689B-3P | 99.70 | 65.71 | 2311 |
| HSA-MIR-3689C | 99.70 | 65.71 | 2311 |
| HSA-MIR-6779-5P | 99.70 | 65.76 | 2363 |
| HSA-MIR-1283 | 99.69 | 72.42 | 3009 |
Functional genomics
ClinGen dosage: haploinsufficiency 40 (dosage sensitivity unlikely), triplosensitivity 0 (no evidence). ClinGen Gene Dosage Map
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ENSDARG00000099590 | |
| danio_rerio | ENSDARG00000101994 | |
| danio_rerio | ENSDARG00000103972 |
Paralogs (12): CENPB (ENSG00000125817), TIGD7 (ENSG00000140993), POGK (ENSG00000143157), POGZ (ENSG00000143442), TIGD4 (ENSG00000169989), TIGD3 (ENSG00000173825), TIGD5 (ENSG00000179886), TIGD2 (ENSG00000180346), JRKL (ENSG00000183340), TIGD1 (ENSG00000221944), JRK (ENSG00000234616), (ENSG00000293642)
Protein
Protein identifiers
Tigger transposable element-derived protein 6 — Q17RP2 (reviewed: Q17RP2)
All UniProt accessions (1): Q17RP2
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Similarity. Belongs to the tigger transposable element derived protein family.
RefSeq proteins (4): NP_001230182, NP_001399099, NP_001399101, NP_112215* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004875 | DDE_SF_endonuclease_dom | Domain |
| IPR006600 | HTH_CenpB_DNA-bd_dom | Domain |
| IPR007889 | HTH_Psq | Domain |
| IPR009057 | Homeodomain-like_sf | Homologous_superfamily |
| IPR050863 | CenT-Element_Derived | Family |
Pfam: PF03184, PF03221, PF04218
UniProt features (9 total): domain 3, DNA-binding region 2, sequence variant 2, chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q17RP2-F1 | 77.19 | 0.29 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 58 (showing top):
PAX4_01, GOZGIT_ESR1_TARGETS_DN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, NRF2_01, CETS1P54_01, AP2GAMMA_01, chr5q32, YGCGYRCGC_UNKNOWN, SCGGAAGY_ELK1_02, AP2ALPHA_01, ELK1_02, ZWANG_DOWN_BY_2ND_EGF_PULSE, KRAS.600.LUNG.BREAST_UP.V1_UP, CHAF1B_TARGET_GENES, CREB3L4_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (2): DNA binding (GO:0003677), nucleic acid binding (GO:0003676)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleic acid binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
472 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TIGD6 | OR52N4 | Q8NGI2 | 474 |
| TIGD6 | ALG1L2 | C9J202 | 470 |
| TIGD6 | ZNF681 | Q96N22 | 446 |
| TIGD6 | CENPBD1P | B2RD01 | 439 |
| TIGD6 | NAIF1 | Q69YI7 | 439 |
| TIGD6 | ZNF648 | Q5T619 | 432 |
| TIGD6 | HMGXB3 | Q12766 | 413 |
| TIGD6 | FOXD4 | Q12950 | 395 |
| TIGD6 | ZNF596 | Q8TC21 | 370 |
| TIGD6 | HARBI1 | Q96MB7 | 370 |
| TIGD6 | TMEM169 | Q96HH4 | 369 |
| TIGD6 | TIGD5 | Q53EQ6 | 365 |
| TIGD6 | SLC35D4 | Q24JQ0 | 359 |
| TIGD6 | A0A087WTP8 | A0A087WTP8 | 358 |
| TIGD6 | GDPD4 | Q6W3E5 | 348 |
| TIGD6 | B3GNT4 | Q9C0J1 | 348 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TIGD6 | MTHFR | psi-mi:“MI:0914”(association) | 0.530 |
| TIGD6 | ZRANB2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (25): ABCF1 (Affinity Capture-MS), ACSL3 (Affinity Capture-MS), MAPT (Affinity Capture-MS), UBE2V2 (Affinity Capture-MS), TAGLN2 (Affinity Capture-MS), MTA1 (Affinity Capture-MS), ZRANB2 (Affinity Capture-MS), SRA1 (Affinity Capture-MS), CHAF1A (Affinity Capture-MS), MAGED2 (Affinity Capture-MS), MRPL13 (Affinity Capture-MS), SS18L2 (Affinity Capture-MS), NUP54 (Affinity Capture-MS), DYNC2H1 (Affinity Capture-MS), SNX27 (Affinity Capture-MS)
ESM2 similar proteins: A4IFA3, A4Z943, A4Z944, A4Z945, B2RRL2, D3Z4R1, F1NQJ3, O43422, O60108, O60290, O96006, P08770, P0CF97, P12258, P16320, P34601, Q09772, Q0VBL1, Q17RP2, Q3EBC8, Q3YK19, Q49AG3, Q4R6P1, Q4W5G0, Q5SVZ6, Q5SXJ3, Q6EKJ0, Q6NT04, Q6R2W3, Q7L775, Q7M3K2, Q86UP8, Q8BUZ3, Q8IY51, Q8IZ13, Q8TBB0, Q8TCP9, Q8TDG4, Q8VEH5, Q95M72
Diamond homologs: P07199, P27790, P48988, P49451, Q17RP2, Q4W5G0, Q6B0B8, Q8IY51, Q8BUZ3, Q6NT04, B2RRL2, O75564, Q0VBL1, Q60976, Q96MW7, Q9Y4A0, Q7TM95
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
96 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 88 |
| Likely benign | 2 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
281 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:149996428:AG:A | acceptor_gain | 0.9900 |
| 5:149996430:C:CC | acceptor_gain | 0.9900 |
| 5:149996427:AAG:A | acceptor_gain | 0.9800 |
| 5:149996428:AGCTG:A | acceptor_loss | 0.9800 |
| 5:149996430:CT:C | acceptor_loss | 0.9800 |
| 5:149996431:T:G | acceptor_loss | 0.9800 |
| 5:149999927:CAGTG:C | donor_gain | 0.9700 |
| 5:150000587:A:AC | donor_gain | 0.9700 |
| 5:150000588:C:CC | donor_gain | 0.9700 |
| 5:149996425:GAAAG:G | acceptor_gain | 0.9600 |
| 5:149996426:AAAG:A | acceptor_gain | 0.9600 |
| 5:150000541:T:TA | donor_gain | 0.9600 |
| 5:149999926:A:AC | donor_gain | 0.9500 |
| 5:149999927:C:CC | donor_gain | 0.9500 |
| 5:149996440:A:T | acceptor_loss | 0.9300 |
| 5:150000216:C:CT | donor_gain | 0.9300 |
| 5:150000217:T:TT | donor_gain | 0.9300 |
| 5:149999927:CA:C | donor_gain | 0.9100 |
| 5:149999991:C:CT | donor_gain | 0.9100 |
| 5:149999992:T:TT | donor_gain | 0.9100 |
| 5:150000213:TCAC:T | donor_gain | 0.9100 |
| 5:150000468:TGTTA:T | donor_loss | 0.9100 |
| 5:150000469:GTTAC:G | donor_loss | 0.9100 |
| 5:150000470:TTACC:T | donor_loss | 0.9100 |
| 5:150000471:TAC:T | donor_loss | 0.9100 |
| 5:150000473:CCTGA:C | donor_loss | 0.9100 |
| 5:150000474:C:A | donor_loss | 0.9000 |
| 5:150000631:C:CA | donor_gain | 0.8900 |
| 5:149999927:CAGT:C | donor_gain | 0.8800 |
| 5:150000588:CTAGA:C | donor_gain | 0.8800 |
AlphaMissense
3490 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:149996238:A:C | F37L | 0.966 |
| 5:149996238:A:T | F37L | 0.966 |
| 5:149996240:A:G | F37L | 0.966 |
| 5:149995968:A:C | F127L | 0.962 |
| 5:149995968:A:T | F127L | 0.962 |
| 5:149995970:A:G | F127L | 0.962 |
| 5:149995998:A:C | F117L | 0.962 |
| 5:149995998:A:T | F117L | 0.962 |
| 5:149996000:A:G | F117L | 0.962 |
| 5:149995982:A:G | W123R | 0.959 |
| 5:149995982:A:T | W123R | 0.959 |
| 5:149995821:A:C | F176L | 0.946 |
| 5:149995821:A:T | F176L | 0.946 |
| 5:149995823:A:G | F176L | 0.946 |
| 5:149996313:G:C | F12L | 0.931 |
| 5:149996313:G:T | F12L | 0.931 |
| 5:149996315:A:G | F12L | 0.931 |
| 5:149996218:A:G | L44S | 0.918 |
| 5:149996233:A:G | I39T | 0.916 |
| 5:149996282:C:G | A23P | 0.912 |
| 5:149995960:C:G | R130P | 0.911 |
| 5:149995969:A:G | F127S | 0.910 |
| 5:149995794:G:C | F185L | 0.907 |
| 5:149995794:G:T | F185L | 0.907 |
| 5:149995796:A:G | F185L | 0.907 |
| 5:149996091:A:C | F86L | 0.907 |
| 5:149996091:A:T | F86L | 0.907 |
| 5:149996093:A:G | F86L | 0.907 |
| 5:149996233:A:C | I39S | 0.906 |
| 5:149995089:A:C | F420L | 0.904 |
dbSNP variants (sampled 300 via entrez): RS1000118570 (5:149999404 T>C), RS1000188063 (5:150000665 G>A), RS1000679417 (5:150000241 G>A), RS1000980030 (5:150000466 C>T), RS1001527020 (5:149995415 G>A), RS1001790575 (5:149997946 G>A), RS1002016821 (5:149995497 G>A), RS1002103904 (5:150000673 A>C,G), RS1002127915 (5:149996614 GATCTT>G), RS1002677824 (5:150000725 C>T), RS1002704710 (5:149995722 C>A,T), RS10036377 (5:149994453 A>G), RS1003745606 (5:150002195 T>C), RS1003812758 (5:150001020 C>G,T), RS1003907917 (5:150000717 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002396_313 | Mean reticulocyte volume | 2.000000e-11 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010701 | mean reticulocyte volume |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| TAK-243 | increases sumoylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| abrine | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Amiodarone | increases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Potassium Chloride | decreases response to substance, decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Dronabinol | decreases response to substance, decreases expression | 1 |
| Triiodothyronine | increases expression | 1 |
| Urethane | increases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.